Clinical Trial Update: A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial update indicates Tessera Therapeutics is evaluating TSRA-196 in adults with Alpha-1 Antitrypsin Deficiency (AATD); the study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-1 Antitrypsin Deficiency

Drugs mentioned

• TSRA-196

Snippet

Sponsor: Tessera Therapeutics, Inc. | Conditions: Alpha-1 Antitrypsin Deficiency (AATD) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING